• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血糖个性:糖尿病护理中以患者为中心选择的SURE框架。

The glycaemic personality: A SURE framework of person-centred choice in diabetes care.

作者信息

Kalra Sanjay, Iraqi Hinde, Sahay Rakesh, Bhattacharya Saptarshi

机构信息

Department of Endocrinology, Bharti Hospital, Karnal, India.

Department of Endocrinology and Diabetology, Ibn Sina Hospital, Rabat, Mohammed V University, Rabat, Morocco.

出版信息

J Pak Med Assoc. 2020 Jul;70(7):1285-1286.

PMID:32799295
Abstract

Diabetology is becoming more and more complex, and requires simple yet comprehensive models to facilitate appropriate management of the syndrome. This communication highlights the concept of glycaemic personality, defined as the sum of all attributes, both biomedical and psychosocial, which influence the glucophenotype of an individual. This concept can be explained by using the SURE model, which lists four factors that influence choice of glucose-lowering therapies and their targets. These include the Severity and Style of hyperglycaemia, Urgency and Utility of glucose control, Relative Risk of hypoglycaemia, and Expected adherence to therapy and Expectations of the person living with diabetes.

摘要

糖尿病学正变得越来越复杂,需要简单而全面的模型来促进对该综合征的恰当管理。本文强调了血糖个性的概念,其定义为影响个体糖表型的所有生物医学和社会心理属性的总和。这一概念可用SURE模型来解释,该模型列出了影响降糖治疗选择及其目标的四个因素。这些因素包括高血糖的严重程度和类型、血糖控制的紧迫性和效用、低血糖的相对风险,以及对治疗的预期依从性和糖尿病患者的期望。

相似文献

1
The glycaemic personality: A SURE framework of person-centred choice in diabetes care.血糖个性:糖尿病护理中以患者为中心选择的SURE框架。
J Pak Med Assoc. 2020 Jul;70(7):1285-1286.
2
Perioperative glycaemic control.围手术期血糖控制
Anaesth Crit Care Pain Med. 2018 Jun;37 Suppl 1:S3-S4. doi: 10.1016/j.accpm.2018.04.007. Epub 2018 Apr 18.
3
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).DEVOTE 研究中的日常禁食血糖变异性:与严重低血糖和心血管结局的关联(DEVOTE2)。
Diabetologia. 2018 Jan;61(1):48-57. doi: 10.1007/s00125-017-4423-z. Epub 2017 Sep 15.
4
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.针对2型糖尿病,强化血糖控制与传统血糖控制的对比研究。
Cochrane Database Syst Rev. 2013 Nov 11(11):CD008143. doi: 10.1002/14651858.CD008143.pub3.
5
Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.血糖变异性和低血糖与胰岛素治疗的 2 型糖尿病患者的 C 肽水平相关。
Diabetes Metab. 2020 Feb;46(1):61-65. doi: 10.1016/j.diabet.2019.02.002. Epub 2019 Feb 21.
6
Oral antidiabetic agents: current role in type 2 diabetes mellitus.口服抗糖尿病药物:在2型糖尿病中的当前作用
Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005.
7
[Treatment of diabetes in metabolic syndrome].[代谢综合征中的糖尿病治疗]
Vnitr Lek. 2009 Jul-Aug;55(7-8):637-45.
8
Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.医学上最大限度减少 2 型糖尿病低血糖的影响:综述。
Expert Opin Pharmacother. 2011 Oct;12(14):2161-75. doi: 10.1517/14656566.2011.589835. Epub 2011 Jun 14.
9
Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.强化血糖控制的利弊,重点关注2型糖尿病
Drugs Aging. 2000 Dec;17(6):463-76. doi: 10.2165/00002512-200017060-00004.
10
The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review.基于患者特征个体化制定 2 型糖尿病血糖目标:范围综述。
Clin Med (Lond). 2022 May;22(3):257-265. doi: 10.7861/clinmed.2021-0764. Epub 2022 Apr 20.

引用本文的文献

1
Barophenotypic Characterization - The key to Person Centric Management of Obesity.巴罗表型特征——以患者为中心的肥胖管理关键
Indian J Endocrinol Metab. 2021 Jul-Aug;25(4):295-298. doi: 10.4103/ijem.ijem_285_21. Epub 2021 Dec 15.